GlassScriptPhysician profile
Barbara Cleino
NPI 1922176536
$10,262.91
in general payments reported to CMS, 2019-2025
50 companies · $886 in 2025
The $886 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,910 · 2022: $2,955 · 2023: $2,621 · 2024: $891 · 2025: $886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,397.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,516.37 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $730.39 | 2021-2025 | Repatha, Otezla, Prolia |
| Abbvie INC. | $698.91 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $661.62 | 2021-2024 | Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $625.85 | 2021-2025 | Jardiance |
| Glaxosmithkline, LLC. | $537.68 | 2021-2023 | Trelegy Ellipta |
| Lilly USA, LLC | $483.05 | 2022-2024 | Mounjaro, Jardiance, Emgality |
| Optinose US, INC. | $477.83 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $350.29 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $343.88 | 2021-2025 | Trintellix |
| Abbott Laboratories | $298.33 | 2021-2023 | Freestyle Libre 2 |
| Biohaven Pharmaceutical Holding Company LTD. | $255.40 | 2022 | |
| Pfizer INC. | $231.60 | 2021-2025 | |
| Axsome Therapeutics, INC. | $218.95 | 2024-2025 | Auvelity, Sunosi |
| Esperion Therapeutics, INC. | $207.16 | 2021-2023 | Nexletol |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Cleino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.